| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.248 | 33.100 | 34.443 | 29.326 | 22.689 | 0 | 19.821 | 7.760 | 22.836 | 22.841 |
| Total Income - EUR | 26.262 | 33.100 | 35.957 | 31.647 | 24.775 | 0 | 19.827 | 7.760 | 22.836 | 22.841 |
| Total Expenses - EUR | 27.616 | 29.890 | 34.392 | 27.768 | 22.943 | 1 | 15.564 | 6.217 | 15.655 | 14.759 |
| Gross Profit/Loss - EUR | -1.354 | 3.210 | 1.565 | 3.879 | 1.833 | -1 | 4.263 | 1.543 | 7.182 | 8.083 |
| Net Profit/Loss - EUR | -2.142 | 2.548 | 1.085 | 3.586 | 1.606 | -1 | 3.900 | 1.329 | 6.056 | 6.944 |
| Employees | 2 | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Dosimaver Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 880 |
| Current Assets | 6.243 | 6.145 | 7.053 | 9.539 | 8.620 | 8.455 | 12.684 | 14.001 | 5.596 | 7.402 |
| Inventories | 5.775 | 4.094 | 5.823 | 4.833 | 0 | 0 | 3.421 | 0 | 0 | 0 |
| Receivables | 449 | 146 | 532 | 723 | 325 | 31 | 0 | 0 | 0 | 6.835 |
| Cash | 19 | 1.905 | 697 | 3.983 | 8.295 | 8.425 | 9.263 | 14.001 | 5.596 | 567 |
| Shareholders Funds | -1.264 | 2.592 | 3.633 | 7.152 | 8.620 | 8.455 | 12.169 | 13.536 | 4.156 | 6.985 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.507 | 3.553 | 3.419 | 2.387 | 0 | 0 | 515 | 465 | 1.440 | 1.297 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4933 - 4933" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Dosimaver Srl